156 related articles for article (PubMed ID: 34246682)
1. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats.
Vivanco-Estela AN; Dos-Santos-Pereira M; Guimaraes FS; Del-Bel E; Nascimento GCD
Neuropharmacology; 2021 Sep; 196():108700. PubMed ID: 34246682
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
Crivelaro do Nascimento G; Ferrari DP; Guimaraes FS; Del Bel EA; Bortolanza M; Ferreira-Junior NC
Neuropharmacology; 2020 Feb; 163():107808. PubMed ID: 31706993
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive action of cannabidiol on thermal sensitivity and post-operative pain in male and female rats.
Arantes ALF; Carvalho MC; Brandão ML; Prado WA; Crippa JAS; Lovick TA; Genaro K
Behav Brain Res; 2024 Feb; 459():114793. PubMed ID: 38048909
[TBL] [Abstract][Full Text] [Related]
4. Nociceptive Response to L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.
Nascimento GC; Bariotto-Dos-Santos K; Leite-Panissi CRA; Del-Bel EA; Bortolanza M
Neurotox Res; 2018 Nov; 34(4):799-807. PubMed ID: 29611150
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors.
Escobar-Espinal DM; Vivanco-Estela AN; Barros N; Dos Santos Pereira M; Guimaraes FS; Del Bel E; Nascimento GC
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jun; 132():110996. PubMed ID: 38508408
[TBL] [Abstract][Full Text] [Related]
6. Intrastriatal Chromospheres' Transplant Reduces Nociception in Hemiparkinsonian Rats.
Gómez-Paz A; Drucker-Colín R; Milán-Aldaco D; Palomero-Rivero M; Ambriz-Tututi M
Neuroscience; 2018 Sep; 387():123-134. PubMed ID: 28890053
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
[TBL] [Abstract][Full Text] [Related]
8. Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.
Teodoro FC; Tronco Júnior MF; Zampronio AR; Martini AC; Rae GA; Chichorro JG
Neuropeptides; 2013 Jun; 47(3):199-206. PubMed ID: 23177733
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain.
Wong H; Cairns BE
Arch Oral Biol; 2019 Aug; 104():33-39. PubMed ID: 31158702
[TBL] [Abstract][Full Text] [Related]
10. Non-Psychoactive Cannabinoid Modulation of Nociception and Inflammation Associated with a Rat Model of Pulpitis.
Laks EY; Li H; Ward SJ
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238715
[TBL] [Abstract][Full Text] [Related]
11. Nigrostriatal dopaminergic depletion produces orofacial static mechanical allodynia.
Dieb W; Ouachikh O; Durif F; Hafidi A
Eur J Pain; 2016 Feb; 20(2):196-205. PubMed ID: 25899074
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors.
Jesus CHA; Redivo DDB; Gasparin AT; Sotomaior BB; de Carvalho MC; Genaro K; Zuardi AW; Hallak JEC; Crippa JA; Zanoveli JM; da Cunha JM
Brain Res; 2019 Jul; 1715():156-164. PubMed ID: 30898678
[TBL] [Abstract][Full Text] [Related]
13. (-)-α-Bisabolol reduces orofacial nociceptive behavior in rodents.
Melo LT; Duailibe MA; Pessoa LM; da Costa FN; Vieira-Neto AE; de Vasconcellos Abdon AP; Campos AR
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):187-195. PubMed ID: 27900410
[TBL] [Abstract][Full Text] [Related]
14. Effects of subthalamic deep brain stimulation with duloxetine on mechanical and thermal thresholds in 6OHDA lesioned rats.
Kaszuba BC; Walling I; Gee LE; Shin DS; Pilitsis JG
Brain Res; 2017 Jan; 1655():233-241. PubMed ID: 27984022
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain.
Razavi Y; Rashvand M; Sharifi A; Haghparast A; Keyhanfar F; Haghparast A
Neurosci Lett; 2021 Sep; 762():136141. PubMed ID: 34324957
[TBL] [Abstract][Full Text] [Related]
16. Diphenyl diselenide reduces mechanical and thermal nociceptive behavioral responses after unilateral intrastriatal administration of 6-hydroxydopamine in rats.
da Rocha JT; Pinton S; Gai BM; Nogueira CW
Biol Trace Elem Res; 2013 Sep; 154(3):372-8. PubMed ID: 23821314
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.
Rodríguez-Muñoz M; Onetti Y; Cortés-Montero E; Garzón J; Sánchez-Blázquez P
Mol Brain; 2018 Sep; 11(1):51. PubMed ID: 30223868
[TBL] [Abstract][Full Text] [Related]
19. Transcranial direct-current stimulation reduces nociceptive behaviour in an orofacial pain model.
Scarabelot VL; de Oliveira C; Medeiros LF; de Macedo IC; Cioato SG; Adachi LNS; Paz AH; de Souza A; Caumo W; Torres ILS
J Oral Rehabil; 2019 Jan; 46(1):40-50. PubMed ID: 30281821
[TBL] [Abstract][Full Text] [Related]
20. Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I).
Schneider T; Zurbriggen L; Dieterle M; Mauermann E; Frei P; Mercer-Chalmers-Bender K; Ruppen W
Pain; 2022 Jan; 163(1):e62-e71. PubMed ID: 34086631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
